ZIMMER BIOMET HOLDINGS, INC. Litigation Settlement, Expense
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Litigation Settlement, Expense of $17.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2026-08-05
- ZIMMER BIOMET HOLDINGS, INC. litigation settlement, expense for the quarter ending 2026-06-30 was $17.80M, a 235.85% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. litigation settlement, expense for the quarter ending 2026-03-31 was $5.00M, a 138.10% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. litigation settlement, expense for the quarter ending 2025-12-31 was $12.30M, a 44.59% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. litigation settlement, expense for the quarter ending 2025-09-30 was $3.10M, a 18.42% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. litigation settlement, expense for fiscal 2025 was $22.70M, a 25.57% decline from fiscal 2024.
- ZIMMER BIOMET HOLDINGS, INC. litigation settlement, expense for fiscal 2024 was $30.50M, a 41.20% increase from fiscal 2023.
- ZIMMER BIOMET HOLDINGS, INC. litigation settlement, expense for fiscal 2023 was $21.60M, a 67.22% decline from fiscal 2022.
- ZIMMER BIOMET HOLDINGS, INC. litigation settlement, expense for fiscal 2022 was $65.90M.
| Period end | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 6 month | Litigation Settlement, Expense 9 month | Litigation Settlement, Expense 12 month | Litigation Settlement, Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $17.80M 10-Q · filed 2026-08-05 | $22.80M 10-Q · filed 2026-08-05 | $35.10M derived: sum of 3 quarters · filed 2026-08-05 | $38.20M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $5.00M 10-Q · filed 2026-05-01 | $17.30M derived: sum of 2 quarters · filed 2026-05-01 | $20.40M derived: sum of 3 quarters · filed 2026-05-01 | $25.70M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $12.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $15.40M derived: sum of 2 quarters · filed 2026-02-20 | $20.70M derived: sum of 3 quarters · filed 2026-08-05 | $22.70M 10-K · filed 2026-02-20 | |
| 2025-09-30 | $3.10M 10-Q · filed 2025-11-05 | $8.40M derived: sum of 2 quarters · filed 2026-08-05 | $10.40M 10-Q · filed 2025-11-05 | $32.70M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $5.30M 10-Q · filed 2026-08-05 | $7.30M 10-Q · filed 2026-08-05 | $29.60M derived: sum of 3 quarters · filed 2026-08-05 | $33.40M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $2.10M 10-Q · filed 2026-05-01 | $24.30M derived: sum of 2 quarters · filed 2026-05-01 | $28.10M derived: sum of 3 quarters · filed 2026-05-01 | $31.50M derived: sum of 4 quarters · filed 2026-05-01 | |
| 2024-12-31 | $22.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $26.00M derived: sum of 2 quarters · filed 2026-02-20 | $29.40M derived: sum of 3 quarters · filed 2026-02-20 | $30.50M 10-K · filed 2026-02-20 | |
| 2024-09-30 | $3.80M 10-Q · filed 2025-11-05 | $7.20M derived: sum of 2 quarters · filed 2025-11-05 | $8.30M 10-Q · filed 2025-11-05 | $26.00M derived: sum of 4 quarters · filed 2026-02-20 | |
| 2024-06-30 | $3.40M 10-Q · filed 2025-08-07 | $4.40M 10-Q · filed 2025-08-07 | $22.20M derived: sum of 3 quarters · filed 2026-02-20 | $24.90M derived: sum of 4 quarters · filed 2026-02-20 | |
| 2024-03-31 | $1.00M 10-Q · filed 2025-05-05 | $18.80M derived: sum of 2 quarters · filed 2026-02-20 | $21.50M derived: sum of 3 quarters · filed 2026-02-20 | $23.70M derived: sum of 4 quarters · filed 2026-02-20 | |
| 2023-12-31 | $17.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $20.50M derived: sum of 2 quarters · filed 2026-02-20 | $22.70M derived: sum of 3 quarters · filed 2026-02-20 | $21.60M 10-K · filed 2026-02-20 | |
| 2023-09-30 | $2.70M 10-Q · filed 2024-10-30 | $4.90M derived: sum of 2 quarters · filed 2024-10-30 | $3.80M 10-Q · filed 2024-10-30 | $39.40M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-06-30 | $2.20M 10-Q · filed 2024-08-07 | $1.10M 10-Q · filed 2024-08-07 | $36.70M derived: sum of 3 quarters · filed 2025-02-25 | $71.40M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-03-31 | $3.30M 10-Q · filed 2024-05-02 | $34.50M derived: sum of 2 quarters · filed 2025-02-25 | $69.20M derived: sum of 3 quarters · filed 2025-02-25 | $69.70M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2022-12-31 | $31.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $65.90M derived: sum of 2 quarters · filed 2025-02-25 | $66.40M derived: sum of 3 quarters · filed 2025-02-25 | $65.90M 10-K · filed 2025-02-25 | |
| 2022-09-30 | $34.70M 10-Q · filed 2023-11-07 | $35.20M derived: sum of 2 quarters · filed 2023-11-07 | $34.70M 10-Q · filed 2022-11-02 | $210.90M derived: sum of 4 quarters · filed 2024-08-07 | |
| 2022-06-30 | $500.00K 10-Q · filed 2022-08-02 | $35.70M 10-Q · filed 2022-08-02 | $176.20M derived: sum of 3 quarters · filed 2024-08-07 | $224.00M derived: sum of 4 quarters · filed 2024-08-07 | |
| 2022-03-31 | $33.20M 10-Q · filed 2023-05-02 | $175.70M derived: sum of 2 quarters · filed 2024-08-07 | $223.50M derived: sum of 3 quarters · filed 2024-08-07 | $223.50M derived: sum of 4 quarters · filed 2024-08-07 | |
| 2021-12-31 | $142.50M derived: 8-K 12 month − 10-Q 9 month · filed 2024-08-07 | $190.30M derived: sum of 2 quarters · filed 2024-08-07 | $190.30M derived: sum of 3 quarters · filed 2024-08-07 | $201.00M 8-K · filed 2024-08-07 | $204.30M 10-K · filed 2022-02-25 |
| 2021-09-30 | $47.80M 10-Q · filed 2022-11-02 | $47.80M derived: sum of 2 quarters · filed 2022-11-02 | $58.50M 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $10.70M 10-Q · filed 2022-08-02 | |||
| 2021-03-31 | $10.70M 10-Q · filed 2022-05-05 | ||||
| 2020-12-31 | $166.00M 10-K · filed 2023-02-24 | $166.90M 10-K · filed 2022-02-25 | |||
| 2019-12-31 | $51.40M 8-K · filed 2022-06-22 | $52.70M 10-K · filed 2022-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |